A citation-based method for searching scientific literature

David W Scott, Rebecca L King, Annette M Staiger, Susana Ben-Neriah, Aixiang Jiang, Heike Horn, Anja Mottok, Pedro Farinha, Graham W Slack, Daisuke Ennishi, Norbert Schmitz, Michael Pfreundschuh, Grzegorz S Nowakowski, Brad S Kahl, Joseph M Connors, Randy D Gascoyne, German Ott, William R Macon, Andreas Rosenwald. Blood 2018
Times Cited: 104

List of shared articles

Times cited

Altered pathways and targeted therapy in double hit lymphoma.
Yuxin Zhuang, Jinxin Che, Meijuan Wu, Yu Guo, Yongjin Xu, Xiaowu Dong, Haiyan Yang. J Hematol Oncol 2022

A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma.
Abdullah Alsuwaidan, Prasad Koduru, Franklin Fuda, Jesse Manuel Jaso, Mingyi Chen, Flavia Rosado, Hung S Luu, Nathan Sweed, Rolando Garcia, Meggie Doucet,[...]. Am J Clin Pathol 2022

Decreased CD11c-positive dendritic cells in the tumor microenvironment predict double-hit/triple-hit genotype and survival in diffuse large B-cell lymphoma.
Chang-Tsu Yuan, Shih-Sung Chuang, Pei-Yuan Cheng, Koping Chang, Hsuan Wang, Jia-Huei Tsai, Jau-Yu Liau, Wen-Chien Chou. J Pathol Clin Res 2022

MYC single-hit large B-cell lymphoma: clinicopathologic difference from MYC-negative large B-cell lymphoma and MYC double-hit/triple-hit lymphoma.
Yoon Ah Cho, Jiyeon Hyeon, Hyunwoo Lee, Junhun Cho, Seok-Jin Kim, Won Seog Kim, Young-Hyeh Ko. Hum Pathol 2021

CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements.
Delin Yuan, Genhong Li, Lian Yu, Yuelong Jiang, Yuanfei Shi, Qiulin Chen, Xiaomei Ma, Lan V Pham, Ken H Young, Manman Deng,[...]. Front Oncol 2021

Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies.
Lucile Bussot, Simon Chevalier, Justine Cristante, Béatrice Grange, Bruno Tesson, Clémence Deteix-Santana, Frédérique Orsini-Piocelle, Cécile Leyronnas, Sophie Dupire, Rémy Gressin,[...]. Br J Haematol 2021

The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.
Jisun Hwang, Chonghyun Suh, Kyungwon Kim, Hosung Kim, Austin I Kim, Jeffrey W Craig, Ke Xun Chen, Joel Roberson, Jeffrey P Guenette, Raymond Y Huang. Cancers (Basel) 2021

Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?
Nicoletta Coccaro, Luisa Anelli, Antonella Zagaria, Tommasina Perrone, Giorgina Specchia, Francesco Albano. Cancers (Basel) 2020

Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and BCL2 gene alterations.
Lina Chen, Kathrin Tyryshkin, Alison Moore, David W Scott, Christian Steidl, Yi Li, Lois E Shepherd, Michael Rauh, Lan Deng, David Good,[...]. Leuk Lymphoma 2020

Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival.
Anurag Mehta, Ajita Verma, Garima Gupta, Rupal Tripathi, Anurag Sharma. Indian J Hematol Blood Transfus 2020

Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled Cohort.
Bogyeong Han, Sehui Kim, Jiwon Koh, Jeemin Yim, Cheol Lee, Dae Seog Heo, Tae Min Kim, Jin Ho Paik, Yoon Kyung Jeon. Cancers (Basel) 2020

Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High Specificity.
Abdullah Alsuwaidan, Elaina Pirruccello, Jesse Jaso, Prasad Koduru, Rolando Garcia, JoEllen Krueger, Meggie Doucet, Rahman Chaudhry, Franklin Fuda, Weina Chen. Cytometry B Clin Cytom 2019

MYC in Germinal Center-derived lymphomas: Mechanisms and therapeutic opportunities.
Andrea Bisso, Arianna Sabò, Bruno Amati. Immunol Rev 2019

Double-hit lymphoma: So what?
Andrew Davies. Hematol Oncol 2019

A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.).
Arianna Di Napoli, D Remotti, C Agostinelli, M R Ambrosio, S Ascani, A Carbone, F Facchetti, S Lazzi, L Leoncini, M Lucioni,[...]. Virchows Arch 2019

Double-hit DLBCL: should we limit FISH testing?
Christiane Copie-Bergman. Blood 2018